News
EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.
Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke patients in the UK, Europe, and US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback